nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—CYSLTR2—hematopoietic system—stomach cancer	0.0236	0.0834	CbGeAlD
Nedocromil—FPR1—hematopoietic system—stomach cancer	0.0213	0.0751	CbGeAlD
Nedocromil—PTGDR—hematopoietic system—stomach cancer	0.0201	0.0709	CbGeAlD
Nedocromil—FPR1—lymphoid tissue—stomach cancer	0.015	0.0529	CbGeAlD
Nedocromil—FPR1—digestive system—stomach cancer	0.0148	0.0522	CbGeAlD
Nedocromil—HSP90AA1—blood vessel—stomach cancer	0.0145	0.0512	CbGeAlD
Nedocromil—PTGDR—digestive system—stomach cancer	0.014	0.0493	CbGeAlD
Nedocromil—FPR1—bone marrow—stomach cancer	0.0136	0.0481	CbGeAlD
Nedocromil—HSP90AA1—gall bladder—stomach cancer	0.0136	0.0481	CbGeAlD
Nedocromil—PTGDR—bone marrow—stomach cancer	0.0129	0.0455	CbGeAlD
Nedocromil—FPR1—endocrine gland—stomach cancer	0.0122	0.0432	CbGeAlD
Nedocromil—CYSLTR1—hematopoietic system—stomach cancer	0.00889	0.0314	CbGeAlD
Nedocromil—PTGDR—lymph node—stomach cancer	0.00798	0.0282	CbGeAlD
Nedocromil—CYSLTR1—smooth muscle tissue—stomach cancer	0.00783	0.0277	CbGeAlD
Nedocromil—HSP90AA1—hematopoietic system—stomach cancer	0.00771	0.0272	CbGeAlD
Nedocromil—CYSLTR1—pancreas—stomach cancer	0.00724	0.0256	CbGeAlD
Nedocromil—HSP90AA1—epithelium—stomach cancer	0.00705	0.0249	CbGeAlD
Nedocromil—HSP90AA1—smooth muscle tissue—stomach cancer	0.00679	0.024	CbGeAlD
Nedocromil—HSP90AA1—pancreas—stomach cancer	0.00628	0.0222	CbGeAlD
Nedocromil—CYSLTR1—lymphoid tissue—stomach cancer	0.00626	0.0221	CbGeAlD
Nedocromil—CYSLTR1—bone marrow—stomach cancer	0.0057	0.0201	CbGeAlD
Nedocromil—HSP90AA1—lymphoid tissue—stomach cancer	0.00543	0.0192	CbGeAlD
Nedocromil—HSP90AA1—digestive system—stomach cancer	0.00536	0.0189	CbGeAlD
Nedocromil—CYSLTR1—endocrine gland—stomach cancer	0.00511	0.018	CbGeAlD
Nedocromil—HSP90AA1—bone marrow—stomach cancer	0.00494	0.0175	CbGeAlD
Nedocromil—HSP90AA1—endocrine gland—stomach cancer	0.00443	0.0157	CbGeAlD
Nedocromil—HSP90AA1—liver—stomach cancer	0.004	0.0141	CbGeAlD
Nedocromil—CYSLTR1—lymph node—stomach cancer	0.00353	0.0125	CbGeAlD
Nedocromil—HSP90AA1—lymph node—stomach cancer	0.00306	0.0108	CbGeAlD
Nedocromil—Rash erythematous—Capecitabine—stomach cancer	0.00205	0.00929	CcSEcCtD
Nedocromil—Otitis media—Capecitabine—stomach cancer	0.00202	0.00914	CcSEcCtD
Nedocromil—Gastrointestinal pain—Floxuridine—stomach cancer	0.00201	0.0091	CcSEcCtD
Nedocromil—Abdominal pain—Floxuridine—stomach cancer	0.00194	0.0088	CcSEcCtD
Nedocromil—Body temperature increased—Floxuridine—stomach cancer	0.00194	0.0088	CcSEcCtD
Nedocromil—Dysphonia—Capecitabine—stomach cancer	0.00191	0.00865	CcSEcCtD
Nedocromil—Hypersensitivity—Floxuridine—stomach cancer	0.00181	0.0082	CcSEcCtD
Nedocromil—Asthenia—Floxuridine—stomach cancer	0.00177	0.00799	CcSEcCtD
Nedocromil—Dyspnoea—Mitomycin—stomach cancer	0.00172	0.00779	CcSEcCtD
Nedocromil—Diarrhoea—Floxuridine—stomach cancer	0.00168	0.00762	CcSEcCtD
Nedocromil—Fatigue—Mitomycin—stomach cancer	0.00166	0.00753	CcSEcCtD
Nedocromil—Pain—Mitomycin—stomach cancer	0.00165	0.00747	CcSEcCtD
Nedocromil—Vomiting—Floxuridine—stomach cancer	0.00156	0.00708	CcSEcCtD
Nedocromil—Rash—Floxuridine—stomach cancer	0.00155	0.00702	CcSEcCtD
Nedocromil—Dermatitis—Floxuridine—stomach cancer	0.00155	0.00701	CcSEcCtD
Nedocromil—Headache—Floxuridine—stomach cancer	0.00154	0.00697	CcSEcCtD
Nedocromil—Body temperature increased—Mitomycin—stomach cancer	0.00153	0.00691	CcSEcCtD
Nedocromil—Nausea—Floxuridine—stomach cancer	0.00146	0.00661	CcSEcCtD
Nedocromil—Rash erythematous—Epirubicin—stomach cancer	0.00143	0.00648	CcSEcCtD
Nedocromil—Otitis media—Epirubicin—stomach cancer	0.00141	0.00637	CcSEcCtD
Nedocromil—Eosinophilia—Fluorouracil—stomach cancer	0.0014	0.00633	CcSEcCtD
Nedocromil—Feeling hot—Epirubicin—stomach cancer	0.0014	0.00632	CcSEcCtD
Nedocromil—Asthenia—Mitomycin—stomach cancer	0.00139	0.00627	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Irinotecan—stomach cancer	0.00137	0.0062	CcSEcCtD
Nedocromil—Stinging—Epirubicin—stomach cancer	0.00135	0.00612	CcSEcCtD
Nedocromil—Ear pain—Capecitabine—stomach cancer	0.00134	0.00606	CcSEcCtD
Nedocromil—Dysphonia—Epirubicin—stomach cancer	0.00133	0.00603	CcSEcCtD
Nedocromil—Rash erythematous—Doxorubicin—stomach cancer	0.00132	0.00599	CcSEcCtD
Nedocromil—Pneumonia—Irinotecan—stomach cancer	0.00132	0.00598	CcSEcCtD
Nedocromil—Diarrhoea—Mitomycin—stomach cancer	0.00132	0.00598	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Fluorouracil—stomach cancer	0.00131	0.00594	CcSEcCtD
Nedocromil—Otitis media—Doxorubicin—stomach cancer	0.0013	0.00589	CcSEcCtD
Nedocromil—Feeling hot—Doxorubicin—stomach cancer	0.00129	0.00585	CcSEcCtD
Nedocromil—Gastroenteritis—Capecitabine—stomach cancer	0.00129	0.00583	CcSEcCtD
Nedocromil—Dizziness—Mitomycin—stomach cancer	0.00128	0.00578	CcSEcCtD
Nedocromil—Pneumonia—Fluorouracil—stomach cancer	0.00127	0.00573	CcSEcCtD
Nedocromil—Stinging—Doxorubicin—stomach cancer	0.00125	0.00566	CcSEcCtD
Nedocromil—Dysphonia—Doxorubicin—stomach cancer	0.00123	0.00558	CcSEcCtD
Nedocromil—Vomiting—Mitomycin—stomach cancer	0.00123	0.00555	CcSEcCtD
Nedocromil—Conjunctivitis—Fluorouracil—stomach cancer	0.00122	0.00554	CcSEcCtD
Nedocromil—Rash—Mitomycin—stomach cancer	0.00122	0.00551	CcSEcCtD
Nedocromil—Dermatitis—Mitomycin—stomach cancer	0.00122	0.0055	CcSEcCtD
Nedocromil—Viral infection—Epirubicin—stomach cancer	0.00121	0.00549	CcSEcCtD
Nedocromil—Headache—Mitomycin—stomach cancer	0.00121	0.00547	CcSEcCtD
Nedocromil—Cough increased—Epirubicin—stomach cancer	0.0012	0.00542	CcSEcCtD
Nedocromil—Rhinitis—Irinotecan—stomach cancer	0.00118	0.00535	CcSEcCtD
Nedocromil—Sinusitis—Fluorouracil—stomach cancer	0.00118	0.00535	CcSEcCtD
Nedocromil—Arthritis—Capecitabine—stomach cancer	0.00117	0.00532	CcSEcCtD
Nedocromil—Nausea—Mitomycin—stomach cancer	0.00115	0.00519	CcSEcCtD
Nedocromil—Visual impairment—Irinotecan—stomach cancer	0.00114	0.00515	CcSEcCtD
Nedocromil—Rhinitis—Fluorouracil—stomach cancer	0.00113	0.00513	CcSEcCtD
Nedocromil—Viral infection—Doxorubicin—stomach cancer	0.00112	0.00508	CcSEcCtD
Nedocromil—Pharyngitis—Fluorouracil—stomach cancer	0.00112	0.00508	CcSEcCtD
Nedocromil—Cough increased—Doxorubicin—stomach cancer	0.00111	0.00501	CcSEcCtD
Nedocromil—Influenza—Capecitabine—stomach cancer	0.000987	0.00447	CcSEcCtD
Nedocromil—Bronchitis—Capecitabine—stomach cancer	0.000949	0.00429	CcSEcCtD
Nedocromil—Leukopenia—Irinotecan—stomach cancer	0.00092	0.00416	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Capecitabine—stomach cancer	0.000917	0.00415	CcSEcCtD
Nedocromil—Pneumonia—Docetaxel—stomach cancer	0.000914	0.00414	CcSEcCtD
Nedocromil—Cough—Irinotecan—stomach cancer	0.000896	0.00406	CcSEcCtD
Nedocromil—Eczema—Epirubicin—stomach cancer	0.000885	0.00401	CcSEcCtD
Nedocromil—Pneumonia—Capecitabine—stomach cancer	0.000885	0.004	CcSEcCtD
Nedocromil—Conjunctivitis—Docetaxel—stomach cancer	0.000883	0.004	CcSEcCtD
Nedocromil—Leukopenia—Fluorouracil—stomach cancer	0.000881	0.00399	CcSEcCtD
Nedocromil—Conjunctivitis—Capecitabine—stomach cancer	0.000855	0.00387	CcSEcCtD
Nedocromil—Anaphylactic shock—Irinotecan—stomach cancer	0.000838	0.00379	CcSEcCtD
Nedocromil—Chest pain—Fluorouracil—stomach cancer	0.000838	0.00379	CcSEcCtD
Nedocromil—Eczema—Doxorubicin—stomach cancer	0.000819	0.00371	CcSEcCtD
Nedocromil—Rhinitis—Docetaxel—stomach cancer	0.000818	0.0037	CcSEcCtD
Nedocromil—Pharyngitis—Docetaxel—stomach cancer	0.00081	0.00366	CcSEcCtD
Nedocromil—Anaphylactic shock—Fluorouracil—stomach cancer	0.000803	0.00363	CcSEcCtD
Nedocromil—Rhinitis—Capecitabine—stomach cancer	0.000792	0.00358	CcSEcCtD
Nedocromil—Visual impairment—Docetaxel—stomach cancer	0.000786	0.00356	CcSEcCtD
Nedocromil—Pharyngitis—Capecitabine—stomach cancer	0.000784	0.00355	CcSEcCtD
Nedocromil—Visual impairment—Capecitabine—stomach cancer	0.000761	0.00344	CcSEcCtD
Nedocromil—Dyspnoea—Irinotecan—stomach cancer	0.000747	0.00338	CcSEcCtD
Nedocromil—Dyspepsia—Irinotecan—stomach cancer	0.000738	0.00334	CcSEcCtD
Nedocromil—Eosinophilia—Methotrexate—stomach cancer	0.000727	0.00329	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000724	0.00328	CcSEcCtD
Nedocromil—Fatigue—Irinotecan—stomach cancer	0.000723	0.00327	CcSEcCtD
Nedocromil—Pain—Irinotecan—stomach cancer	0.000717	0.00324	CcSEcCtD
Nedocromil—Dyspnoea—Fluorouracil—stomach cancer	0.000716	0.00324	CcSEcCtD
Nedocromil—Dyspepsia—Fluorouracil—stomach cancer	0.000707	0.0032	CcSEcCtD
Nedocromil—Dysgeusia—Docetaxel—stomach cancer	0.000695	0.00315	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000693	0.00314	CcSEcCtD
Nedocromil—Influenza—Epirubicin—stomach cancer	0.000687	0.00311	CcSEcCtD
Nedocromil—Pain—Fluorouracil—stomach cancer	0.000687	0.00311	CcSEcCtD
Nedocromil—Gastrointestinal pain—Irinotecan—stomach cancer	0.000686	0.0031	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Methotrexate—stomach cancer	0.000683	0.00309	CcSEcCtD
Nedocromil—Eosinophilia—Epirubicin—stomach cancer	0.000681	0.00308	CcSEcCtD
Nedocromil—Dysgeusia—Capecitabine—stomach cancer	0.000673	0.00305	CcSEcCtD
Nedocromil—Abdominal pain—Irinotecan—stomach cancer	0.000663	0.003	CcSEcCtD
Nedocromil—Body temperature increased—Irinotecan—stomach cancer	0.000663	0.003	CcSEcCtD
Nedocromil—Bronchitis—Epirubicin—stomach cancer	0.000661	0.00299	CcSEcCtD
Nedocromil—Pneumonia—Methotrexate—stomach cancer	0.000659	0.00298	CcSEcCtD
Nedocromil—Tremor—Capecitabine—stomach cancer	0.000644	0.00292	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Epirubicin—stomach cancer	0.000639	0.00289	CcSEcCtD
Nedocromil—Urticaria—Fluorouracil—stomach cancer	0.000638	0.00289	CcSEcCtD
Nedocromil—Conjunctivitis—Methotrexate—stomach cancer	0.000637	0.00288	CcSEcCtD
Nedocromil—Influenza—Doxorubicin—stomach cancer	0.000636	0.00288	CcSEcCtD
Nedocromil—Leukopenia—Docetaxel—stomach cancer	0.000636	0.00288	CcSEcCtD
Nedocromil—Body temperature increased—Fluorouracil—stomach cancer	0.000635	0.00287	CcSEcCtD
Nedocromil—Eosinophilia—Doxorubicin—stomach cancer	0.00063	0.00285	CcSEcCtD
Nedocromil—Cough—Docetaxel—stomach cancer	0.00062	0.0028	CcSEcCtD
Nedocromil—Hypersensitivity—Irinotecan—stomach cancer	0.000618	0.0028	CcSEcCtD
Nedocromil—Pneumonia—Epirubicin—stomach cancer	0.000617	0.00279	CcSEcCtD
Nedocromil—Leukopenia—Capecitabine—stomach cancer	0.000615	0.00279	CcSEcCtD
Nedocromil—Bronchitis—Doxorubicin—stomach cancer	0.000612	0.00277	CcSEcCtD
Nedocromil—Chest pain—Docetaxel—stomach cancer	0.000605	0.00274	CcSEcCtD
Nedocromil—Asthenia—Irinotecan—stomach cancer	0.000602	0.00272	CcSEcCtD
Nedocromil—Cough—Capecitabine—stomach cancer	0.0006	0.00272	CcSEcCtD
Nedocromil—Conjunctivitis—Epirubicin—stomach cancer	0.000596	0.0027	CcSEcCtD
Nedocromil—Hypersensitivity—Fluorouracil—stomach cancer	0.000592	0.00268	CcSEcCtD
Nedocromil—Dry mouth—Docetaxel—stomach cancer	0.000591	0.00268	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000591	0.00268	CcSEcCtD
Nedocromil—Chest pain—Capecitabine—stomach cancer	0.000585	0.00265	CcSEcCtD
Nedocromil—Pharyngitis—Methotrexate—stomach cancer	0.000584	0.00264	CcSEcCtD
Nedocromil—Anaphylactic shock—Docetaxel—stomach cancer	0.00058	0.00262	CcSEcCtD
Nedocromil—Sinusitis—Epirubicin—stomach cancer	0.000575	0.0026	CcSEcCtD
Nedocromil—Diarrhoea—Irinotecan—stomach cancer	0.000574	0.0026	CcSEcCtD
Nedocromil—Dry mouth—Capecitabine—stomach cancer	0.000572	0.00259	CcSEcCtD
Nedocromil—Pneumonia—Doxorubicin—stomach cancer	0.00057	0.00258	CcSEcCtD
Nedocromil—Visual impairment—Methotrexate—stomach cancer	0.000567	0.00256	CcSEcCtD
Nedocromil—Dizziness—Irinotecan—stomach cancer	0.000554	0.00251	CcSEcCtD
Nedocromil—Rhinitis—Epirubicin—stomach cancer	0.000552	0.0025	CcSEcCtD
Nedocromil—Conjunctivitis—Doxorubicin—stomach cancer	0.000551	0.00249	CcSEcCtD
Nedocromil—Diarrhoea—Fluorouracil—stomach cancer	0.000549	0.00249	CcSEcCtD
Nedocromil—Pharyngitis—Epirubicin—stomach cancer	0.000546	0.00247	CcSEcCtD
Nedocromil—Vomiting—Irinotecan—stomach cancer	0.000533	0.00241	CcSEcCtD
Nedocromil—Sinusitis—Doxorubicin—stomach cancer	0.000532	0.00241	CcSEcCtD
Nedocromil—Dizziness—Fluorouracil—stomach cancer	0.000531	0.0024	CcSEcCtD
Nedocromil—Visual impairment—Epirubicin—stomach cancer	0.00053	0.0024	CcSEcCtD
Nedocromil—Rash—Irinotecan—stomach cancer	0.000529	0.00239	CcSEcCtD
Nedocromil—Dermatitis—Irinotecan—stomach cancer	0.000528	0.00239	CcSEcCtD
Nedocromil—Headache—Irinotecan—stomach cancer	0.000525	0.00238	CcSEcCtD
Nedocromil—Dyspnoea—Docetaxel—stomach cancer	0.000517	0.00234	CcSEcCtD
Nedocromil—Vomiting—Fluorouracil—stomach cancer	0.000511	0.00231	CcSEcCtD
Nedocromil—Rhinitis—Doxorubicin—stomach cancer	0.00051	0.00231	CcSEcCtD
Nedocromil—Dyspepsia—Docetaxel—stomach cancer	0.00051	0.00231	CcSEcCtD
Nedocromil—Rash—Fluorouracil—stomach cancer	0.000506	0.00229	CcSEcCtD
Nedocromil—Dermatitis—Fluorouracil—stomach cancer	0.000506	0.00229	CcSEcCtD
Nedocromil—Pharyngitis—Doxorubicin—stomach cancer	0.000505	0.00229	CcSEcCtD
Nedocromil—Headache—Fluorouracil—stomach cancer	0.000503	0.00228	CcSEcCtD
Nedocromil—Dysgeusia—Methotrexate—stomach cancer	0.000501	0.00227	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Docetaxel—stomach cancer	0.0005	0.00226	CcSEcCtD
Nedocromil—Dyspnoea—Capecitabine—stomach cancer	0.0005	0.00226	CcSEcCtD
Nedocromil—Fatigue—Docetaxel—stomach cancer	0.0005	0.00226	CcSEcCtD
Nedocromil—Nausea—Irinotecan—stomach cancer	0.000498	0.00225	CcSEcCtD
Nedocromil—Pain—Docetaxel—stomach cancer	0.000496	0.00224	CcSEcCtD
Nedocromil—Dyspepsia—Capecitabine—stomach cancer	0.000494	0.00224	CcSEcCtD
Nedocromil—Visual impairment—Doxorubicin—stomach cancer	0.000491	0.00222	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000484	0.00219	CcSEcCtD
Nedocromil—Fatigue—Capecitabine—stomach cancer	0.000484	0.00219	CcSEcCtD
Nedocromil—Pain—Capecitabine—stomach cancer	0.00048	0.00217	CcSEcCtD
Nedocromil—Nausea—Fluorouracil—stomach cancer	0.000477	0.00216	CcSEcCtD
Nedocromil—Gastrointestinal pain—Docetaxel—stomach cancer	0.000474	0.00214	CcSEcCtD
Nedocromil—Dysgeusia—Epirubicin—stomach cancer	0.000469	0.00212	CcSEcCtD
Nedocromil—Gastrointestinal pain—Capecitabine—stomach cancer	0.000459	0.00208	CcSEcCtD
Nedocromil—Body temperature increased—Docetaxel—stomach cancer	0.000458	0.00207	CcSEcCtD
Nedocromil—Abdominal pain—Docetaxel—stomach cancer	0.000458	0.00207	CcSEcCtD
Nedocromil—Leukopenia—Methotrexate—stomach cancer	0.000458	0.00207	CcSEcCtD
Nedocromil—Cough—Methotrexate—stomach cancer	0.000447	0.00202	CcSEcCtD
Nedocromil—Urticaria—Capecitabine—stomach cancer	0.000446	0.00202	CcSEcCtD
Nedocromil—Body temperature increased—Capecitabine—stomach cancer	0.000444	0.00201	CcSEcCtD
Nedocromil—Abdominal pain—Capecitabine—stomach cancer	0.000444	0.00201	CcSEcCtD
Nedocromil—Chest pain—Methotrexate—stomach cancer	0.000436	0.00197	CcSEcCtD
Nedocromil—Dysgeusia—Doxorubicin—stomach cancer	0.000434	0.00196	CcSEcCtD
Nedocromil—Leukopenia—Epirubicin—stomach cancer	0.000429	0.00194	CcSEcCtD
Nedocromil—Hypersensitivity—Docetaxel—stomach cancer	0.000427	0.00193	CcSEcCtD
Nedocromil—Cough—Epirubicin—stomach cancer	0.000418	0.00189	CcSEcCtD
Nedocromil—Anaphylactic shock—Methotrexate—stomach cancer	0.000418	0.00189	CcSEcCtD
Nedocromil—Asthenia—Docetaxel—stomach cancer	0.000416	0.00188	CcSEcCtD
Nedocromil—Hypersensitivity—Capecitabine—stomach cancer	0.000413	0.00187	CcSEcCtD
Nedocromil—Chest pain—Epirubicin—stomach cancer	0.000408	0.00185	CcSEcCtD
Nedocromil—Asthenia—Capecitabine—stomach cancer	0.000403	0.00182	CcSEcCtD
Nedocromil—Dry mouth—Epirubicin—stomach cancer	0.000399	0.0018	CcSEcCtD
Nedocromil—Leukopenia—Doxorubicin—stomach cancer	0.000397	0.0018	CcSEcCtD
Nedocromil—Diarrhoea—Docetaxel—stomach cancer	0.000397	0.00179	CcSEcCtD
Nedocromil—Anaphylactic shock—Epirubicin—stomach cancer	0.000391	0.00177	CcSEcCtD
Nedocromil—Cough—Doxorubicin—stomach cancer	0.000387	0.00175	CcSEcCtD
Nedocromil—Diarrhoea—Capecitabine—stomach cancer	0.000384	0.00174	CcSEcCtD
Nedocromil—Dizziness—Docetaxel—stomach cancer	0.000383	0.00173	CcSEcCtD
Nedocromil—Chest pain—Doxorubicin—stomach cancer	0.000377	0.00171	CcSEcCtD
Nedocromil—Dyspnoea—Methotrexate—stomach cancer	0.000372	0.00169	CcSEcCtD
Nedocromil—Dizziness—Capecitabine—stomach cancer	0.000371	0.00168	CcSEcCtD
Nedocromil—Dry mouth—Doxorubicin—stomach cancer	0.000369	0.00167	CcSEcCtD
Nedocromil—Vomiting—Docetaxel—stomach cancer	0.000369	0.00167	CcSEcCtD
Nedocromil—Dyspepsia—Methotrexate—stomach cancer	0.000368	0.00166	CcSEcCtD
Nedocromil—Rash—Docetaxel—stomach cancer	0.000365	0.00165	CcSEcCtD
Nedocromil—Dermatitis—Docetaxel—stomach cancer	0.000365	0.00165	CcSEcCtD
Nedocromil—Headache—Docetaxel—stomach cancer	0.000363	0.00164	CcSEcCtD
Nedocromil—Anaphylactic shock—Doxorubicin—stomach cancer	0.000362	0.00164	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000361	0.00163	CcSEcCtD
Nedocromil—Fatigue—Methotrexate—stomach cancer	0.00036	0.00163	CcSEcCtD
Nedocromil—Pain—Methotrexate—stomach cancer	0.000357	0.00162	CcSEcCtD
Nedocromil—Vomiting—Capecitabine—stomach cancer	0.000357	0.00161	CcSEcCtD
Nedocromil—Rash—Capecitabine—stomach cancer	0.000354	0.0016	CcSEcCtD
Nedocromil—Dermatitis—Capecitabine—stomach cancer	0.000353	0.0016	CcSEcCtD
Nedocromil—Headache—Capecitabine—stomach cancer	0.000352	0.00159	CcSEcCtD
Nedocromil—Dyspnoea—Epirubicin—stomach cancer	0.000349	0.00158	CcSEcCtD
Nedocromil—Nausea—Docetaxel—stomach cancer	0.000344	0.00156	CcSEcCtD
Nedocromil—Dyspepsia—Epirubicin—stomach cancer	0.000344	0.00156	CcSEcCtD
Nedocromil—Gastrointestinal pain—Methotrexate—stomach cancer	0.000342	0.00155	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000337	0.00153	CcSEcCtD
Nedocromil—Fatigue—Epirubicin—stomach cancer	0.000337	0.00153	CcSEcCtD
Nedocromil—Pain—Epirubicin—stomach cancer	0.000334	0.00151	CcSEcCtD
Nedocromil—Nausea—Capecitabine—stomach cancer	0.000333	0.00151	CcSEcCtD
Nedocromil—Urticaria—Methotrexate—stomach cancer	0.000332	0.0015	CcSEcCtD
Nedocromil—Abdominal pain—Methotrexate—stomach cancer	0.00033	0.00149	CcSEcCtD
Nedocromil—Body temperature increased—Methotrexate—stomach cancer	0.00033	0.00149	CcSEcCtD
Nedocromil—Dyspnoea—Doxorubicin—stomach cancer	0.000322	0.00146	CcSEcCtD
Nedocromil—Gastrointestinal pain—Epirubicin—stomach cancer	0.00032	0.00145	CcSEcCtD
Nedocromil—Dyspepsia—Doxorubicin—stomach cancer	0.000318	0.00144	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000312	0.00141	CcSEcCtD
Nedocromil—Fatigue—Doxorubicin—stomach cancer	0.000312	0.00141	CcSEcCtD
Nedocromil—Urticaria—Epirubicin—stomach cancer	0.000311	0.00141	CcSEcCtD
Nedocromil—Pain—Doxorubicin—stomach cancer	0.000309	0.0014	CcSEcCtD
Nedocromil—Abdominal pain—Epirubicin—stomach cancer	0.000309	0.0014	CcSEcCtD
Nedocromil—Body temperature increased—Epirubicin—stomach cancer	0.000309	0.0014	CcSEcCtD
Nedocromil—Hypersensitivity—Methotrexate—stomach cancer	0.000308	0.00139	CcSEcCtD
Nedocromil—Asthenia—Methotrexate—stomach cancer	0.0003	0.00136	CcSEcCtD
Nedocromil—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000296	0.00134	CcSEcCtD
Nedocromil—Hypersensitivity—Epirubicin—stomach cancer	0.000288	0.0013	CcSEcCtD
Nedocromil—Urticaria—Doxorubicin—stomach cancer	0.000287	0.0013	CcSEcCtD
Nedocromil—Body temperature increased—Doxorubicin—stomach cancer	0.000286	0.00129	CcSEcCtD
Nedocromil—Abdominal pain—Doxorubicin—stomach cancer	0.000286	0.00129	CcSEcCtD
Nedocromil—Diarrhoea—Methotrexate—stomach cancer	0.000286	0.00129	CcSEcCtD
Nedocromil—Asthenia—Epirubicin—stomach cancer	0.00028	0.00127	CcSEcCtD
Nedocromil—Dizziness—Methotrexate—stomach cancer	0.000276	0.00125	CcSEcCtD
Nedocromil—Diarrhoea—Epirubicin—stomach cancer	0.000267	0.00121	CcSEcCtD
Nedocromil—Hypersensitivity—Doxorubicin—stomach cancer	0.000266	0.00121	CcSEcCtD
Nedocromil—Vomiting—Methotrexate—stomach cancer	0.000266	0.0012	CcSEcCtD
Nedocromil—Rash—Methotrexate—stomach cancer	0.000263	0.00119	CcSEcCtD
Nedocromil—Dermatitis—Methotrexate—stomach cancer	0.000263	0.00119	CcSEcCtD
Nedocromil—Headache—Methotrexate—stomach cancer	0.000262	0.00118	CcSEcCtD
Nedocromil—Asthenia—Doxorubicin—stomach cancer	0.00026	0.00117	CcSEcCtD
Nedocromil—Dizziness—Epirubicin—stomach cancer	0.000259	0.00117	CcSEcCtD
Nedocromil—Vomiting—Epirubicin—stomach cancer	0.000249	0.00112	CcSEcCtD
Nedocromil—Nausea—Methotrexate—stomach cancer	0.000248	0.00112	CcSEcCtD
Nedocromil—Diarrhoea—Doxorubicin—stomach cancer	0.000247	0.00112	CcSEcCtD
Nedocromil—Rash—Epirubicin—stomach cancer	0.000246	0.00112	CcSEcCtD
Nedocromil—Dermatitis—Epirubicin—stomach cancer	0.000246	0.00111	CcSEcCtD
Nedocromil—Headache—Epirubicin—stomach cancer	0.000245	0.00111	CcSEcCtD
Nedocromil—Dizziness—Doxorubicin—stomach cancer	0.000239	0.00108	CcSEcCtD
Nedocromil—Nausea—Epirubicin—stomach cancer	0.000232	0.00105	CcSEcCtD
Nedocromil—Vomiting—Doxorubicin—stomach cancer	0.00023	0.00104	CcSEcCtD
Nedocromil—Rash—Doxorubicin—stomach cancer	0.000228	0.00103	CcSEcCtD
Nedocromil—Dermatitis—Doxorubicin—stomach cancer	0.000228	0.00103	CcSEcCtD
Nedocromil—Headache—Doxorubicin—stomach cancer	0.000227	0.00103	CcSEcCtD
Nedocromil—Nausea—Doxorubicin—stomach cancer	0.000215	0.000972	CcSEcCtD
Nedocromil—HSP90AA1—Signaling Pathways—HTR1A—stomach cancer	7.1e-05	0.000143	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—APC—stomach cancer	7.09e-05	0.000143	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MMP9—stomach cancer	7.06e-05	0.000142	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CDKN1B—stomach cancer	7.06e-05	0.000142	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—ERBB2—stomach cancer	7.01e-05	0.000141	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SMAD4—stomach cancer	6.99e-05	0.000141	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—RHOA—stomach cancer	6.98e-05	0.000141	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CXCL8—stomach cancer	6.89e-05	0.000139	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ANXA1—stomach cancer	6.85e-05	0.000138	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—HRAS—stomach cancer	6.84e-05	0.000138	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SMAD4—stomach cancer	6.82e-05	0.000137	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—MAPK3—stomach cancer	6.79e-05	0.000137	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—FGFR2—stomach cancer	6.75e-05	0.000136	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CXCL8—stomach cancer	6.74e-05	0.000136	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CCND1—stomach cancer	6.74e-05	0.000136	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CDKN1B—stomach cancer	6.74e-05	0.000136	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CDKN1B—stomach cancer	6.73e-05	0.000136	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CXCL8—stomach cancer	6.65e-05	0.000134	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ADRB1—stomach cancer	6.64e-05	0.000134	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—FYN—stomach cancer	6.63e-05	0.000134	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—HRAS—stomach cancer	6.61e-05	0.000133	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL6R—stomach cancer	6.58e-05	0.000133	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—IL6—stomach cancer	6.55e-05	0.000132	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CDKN1A—stomach cancer	6.52e-05	0.000131	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CDKN1B—stomach cancer	6.5e-05	0.000131	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FYN—stomach cancer	6.47e-05	0.000131	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—MAPK1—stomach cancer	6.46e-05	0.00013	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—EGFR—stomach cancer	6.46e-05	0.00013	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—HRAS—stomach cancer	6.42e-05	0.00013	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCND1—stomach cancer	6.42e-05	0.000129	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—JUN—stomach cancer	6.41e-05	0.000129	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—JUN—stomach cancer	6.4e-05	0.000129	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ERCC2—stomach cancer	6.38e-05	0.000129	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—VEGFA—stomach cancer	6.34e-05	0.000128	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—RPS6—stomach cancer	6.34e-05	0.000128	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL6—stomach cancer	6.33e-05	0.000128	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PPP2R1A—stomach cancer	6.3e-05	0.000127	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—STAT3—stomach cancer	6.28e-05	0.000127	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MMP9—stomach cancer	6.23e-05	0.000126	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—FGFR2—stomach cancer	6.23e-05	0.000126	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CDKN1A—stomach cancer	6.22e-05	0.000125	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—MAPK3—stomach cancer	6.21e-05	0.000125	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CDKN1A—stomach cancer	6.21e-05	0.000125	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCND1—stomach cancer	6.2e-05	0.000125	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—JUN—stomach cancer	6.18e-05	0.000125	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GSTP1—stomach cancer	6.18e-05	0.000125	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IRS2—stomach cancer	6.18e-05	0.000125	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—PIK3CA—stomach cancer	6.17e-05	0.000124	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SERPINE1—stomach cancer	6.16e-05	0.000124	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—IL6—stomach cancer	6.15e-05	0.000124	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CXCL8—stomach cancer	6.12e-05	0.000124	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—KRAS—stomach cancer	6.1e-05	0.000123	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—HMOX1—stomach cancer	6.1e-05	0.000123	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FGFR2—stomach cancer	6.08e-05	0.000123	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—MAPK8—stomach cancer	6.07e-05	0.000122	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MAPK8—stomach cancer	6.06e-05	0.000122	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—MYC—stomach cancer	6.04e-05	0.000122	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MMP9—stomach cancer	6.02e-05	0.000121	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MAPK3—stomach cancer	6e-05	0.000121	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CDKN1A—stomach cancer	6e-05	0.000121	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MTHFR—stomach cancer	5.99e-05	0.000121	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—RHOA—stomach cancer	5.95e-05	0.00012	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—MAPK1—stomach cancer	5.91e-05	0.000119	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NOS3—stomach cancer	5.88e-05	0.000119	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MAPK8—stomach cancer	5.85e-05	0.000118	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HBEGF—stomach cancer	5.83e-05	0.000117	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—TYMS—stomach cancer	5.75e-05	0.000116	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MAPK1—stomach cancer	5.71e-05	0.000115	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—EGFR—stomach cancer	5.71e-05	0.000115	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IRS2—stomach cancer	5.7e-05	0.000115	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PRKCB—stomach cancer	5.7e-05	0.000115	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GSTM1—stomach cancer	5.68e-05	0.000115	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL6ST—stomach cancer	5.68e-05	0.000114	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—PIK3CA—stomach cancer	5.61e-05	0.000113	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—VEGFA—stomach cancer	5.59e-05	0.000113	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IRS2—stomach cancer	5.56e-05	0.000112	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MAPK3—stomach cancer	5.55e-05	0.000112	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—STAT3—stomach cancer	5.54e-05	0.000112	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CAV1—stomach cancer	5.53e-05	0.000111	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—APOA1—stomach cancer	5.52e-05	0.000111	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ERBB2—stomach cancer	5.5e-05	0.000111	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TNF—stomach cancer	5.44e-05	0.00011	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—VEGFA—stomach cancer	5.4e-05	0.000109	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MYC—stomach cancer	5.4e-05	0.000109	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CAV1—stomach cancer	5.39e-05	0.000109	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—KRAS—stomach cancer	5.39e-05	0.000109	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—APOA1—stomach cancer	5.38e-05	0.000109	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ADRB2—stomach cancer	5.38e-05	0.000108	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—STAT3—stomach cancer	5.35e-05	0.000108	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ERCC2—stomach cancer	5.34e-05	0.000108	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—MAPK3—stomach cancer	5.3e-05	0.000107	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MAPK3—stomach cancer	5.29e-05	0.000107	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MAPK1—stomach cancer	5.29e-05	0.000107	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PPP2R1A—stomach cancer	5.27e-05	0.000106	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IL6ST—stomach cancer	5.24e-05	0.000106	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CXCL8—stomach cancer	5.22e-05	0.000105	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—HRAS—stomach cancer	5.19e-05	0.000105	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MYC—stomach cancer	5.15e-05	0.000104	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PRKCB—stomach cancer	5.13e-05	0.000104	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL6ST—stomach cancer	5.11e-05	0.000103	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MAPK3—stomach cancer	5.11e-05	0.000103	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CDKN1B—stomach cancer	5.1e-05	0.000103	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CASP8—stomach cancer	5.08e-05	0.000102	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL6R—stomach cancer	5.07e-05	0.000102	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—MAPK1—stomach cancer	5.04e-05	0.000102	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—EGFR—stomach cancer	5.04e-05	0.000102	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—APC—stomach cancer	5.04e-05	0.000102	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MAPK1—stomach cancer	5.04e-05	0.000102	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—EGFR—stomach cancer	5.03e-05	0.000102	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CDH1—stomach cancer	5.02e-05	0.000101	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—MTHFR—stomach cancer	5.02e-05	0.000101	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MYC—stomach cancer	4.97e-05	0.0001	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL6—stomach cancer	4.96e-05	0.0001	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—APC—stomach cancer	4.91e-05	9.91e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SMAD4—stomach cancer	4.89e-05	9.87e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MAPK1—stomach cancer	4.86e-05	9.81e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCND1—stomach cancer	4.86e-05	9.81e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—EGFR—stomach cancer	4.86e-05	9.8e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—JUN—stomach cancer	4.85e-05	9.79e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—KRAS—stomach cancer	4.76e-05	9.6e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—KRAS—stomach cancer	4.76e-05	9.59e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MMP9—stomach cancer	4.72e-05	9.52e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—MAPK3—stomach cancer	4.71e-05	9.49e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CDKN1A—stomach cancer	4.7e-05	9.49e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IL6R—stomach cancer	4.68e-05	9.43e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FYN—stomach cancer	4.65e-05	9.37e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CAV1—stomach cancer	4.63e-05	9.34e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—APOA1—stomach cancer	4.62e-05	9.32e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—KRAS—stomach cancer	4.59e-05	9.26e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MAPK8—stomach cancer	4.59e-05	9.26e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—HRAS—stomach cancer	4.58e-05	9.24e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL6R—stomach cancer	4.56e-05	9.2e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—MAPK1—stomach cancer	4.48e-05	9.03e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—EGFR—stomach cancer	4.48e-05	9.03e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TP53—stomach cancer	4.44e-05	8.95e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—IL6—stomach cancer	4.39e-05	8.85e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SERPINE1—stomach cancer	4.38e-05	8.83e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—PIK3CA—stomach cancer	4.38e-05	8.82e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PIK3CA—stomach cancer	4.37e-05	8.81e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FGFR2—stomach cancer	4.36e-05	8.79e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—PIK3CA—stomach cancer	4.28e-05	8.63e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SERPINE1—stomach cancer	4.27e-05	8.61e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—VEGFA—stomach cancer	4.24e-05	8.55e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ERBB2—stomach cancer	4.24e-05	8.54e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—KRAS—stomach cancer	4.23e-05	8.53e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TP53—stomach cancer	4.23e-05	8.52e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—RHOA—stomach cancer	4.22e-05	8.52e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PIK3CA—stomach cancer	4.22e-05	8.51e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—STAT3—stomach cancer	4.2e-05	8.46e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOS3—stomach cancer	4.18e-05	8.43e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—RHOA—stomach cancer	4.12e-05	8.31e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TP53—stomach cancer	4.08e-05	8.23e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NOS3—stomach cancer	4.08e-05	8.22e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PPARG—stomach cancer	4.07e-05	8.21e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—HRAS—stomach cancer	4.05e-05	8.16e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HRAS—stomach cancer	4.04e-05	8.15e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MAPK3—stomach cancer	4.01e-05	8.09e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IRS2—stomach cancer	3.99e-05	8.05e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CDKN1B—stomach cancer	3.92e-05	7.91e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ERBB2—stomach cancer	3.91e-05	7.89e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HRAS—stomach cancer	3.9e-05	7.87e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MYC—stomach cancer	3.9e-05	7.87e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—PIK3CA—stomach cancer	3.89e-05	7.83e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—IL6—stomach cancer	3.87e-05	7.81e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CAV1—stomach cancer	3.87e-05	7.81e-05	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL6—stomach cancer	3.87e-05	7.8e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APOA1—stomach cancer	3.86e-05	7.79e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL1B—stomach cancer	3.85e-05	7.77e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PTGS2—stomach cancer	3.82e-05	7.71e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MAPK1—stomach cancer	3.82e-05	7.69e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ERBB2—stomach cancer	3.82e-05	7.69e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—EGFR—stomach cancer	3.82e-05	7.69e-05	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL6—stomach cancer	3.74e-05	7.53e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—JUN—stomach cancer	3.73e-05	7.53e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PRKCB—stomach cancer	3.69e-05	7.43e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL6ST—stomach cancer	3.67e-05	7.4e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ALB—stomach cancer	3.66e-05	7.38e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CDKN1B—stomach cancer	3.62e-05	7.3e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CDKN1A—stomach cancer	3.62e-05	7.3e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CXCL8—stomach cancer	3.62e-05	7.3e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—KRAS—stomach cancer	3.6e-05	7.27e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—HRAS—stomach cancer	3.59e-05	7.25e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MAPK8—stomach cancer	3.53e-05	7.12e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CDKN1B—stomach cancer	3.53e-05	7.12e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APC—stomach cancer	3.53e-05	7.11e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—NOS3—stomach cancer	3.5e-05	7.06e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL6—stomach cancer	3.44e-05	6.94e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCND1—stomach cancer	3.37e-05	6.8e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—JUN—stomach cancer	3.36e-05	6.78e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CDKN1A—stomach cancer	3.34e-05	6.74e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PIK3CA—stomach cancer	3.31e-05	6.68e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL6R—stomach cancer	3.27e-05	6.6e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MMP9—stomach cancer	3.27e-05	6.6e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CDKN1A—stomach cancer	3.26e-05	6.58e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—STAT3—stomach cancer	3.23e-05	6.51e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TP53—stomach cancer	3.2e-05	6.46e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PTGS2—stomach cancer	3.2e-05	6.46e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MAPK8—stomach cancer	3.18e-05	6.42e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MAPK3—stomach cancer	3.09e-05	6.22e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SERPINE1—stomach cancer	3.07e-05	6.18e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HRAS—stomach cancer	3.06e-05	6.18e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—STAT3—stomach cancer	2.98e-05	6.01e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—RHOA—stomach cancer	2.96e-05	5.97e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—VEGFA—stomach cancer	2.94e-05	5.93e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MAPK1—stomach cancer	2.94e-05	5.92e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—EGFR—stomach cancer	2.94e-05	5.92e-05	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL6—stomach cancer	2.93e-05	5.91e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NOS3—stomach cancer	2.93e-05	5.9e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—STAT3—stomach cancer	2.91e-05	5.87e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MAPK3—stomach cancer	2.85e-05	5.75e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MAPK3—stomach cancer	2.78e-05	5.61e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—KRAS—stomach cancer	2.77e-05	5.59e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MYC—stomach cancer	2.77e-05	5.59e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ERBB2—stomach cancer	2.74e-05	5.52e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MAPK1—stomach cancer	2.71e-05	5.47e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—EGFR—stomach cancer	2.71e-05	5.47e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MYC—stomach cancer	2.7e-05	5.45e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MAPK1—stomach cancer	2.65e-05	5.33e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EGFR—stomach cancer	2.64e-05	5.33e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCL8—stomach cancer	2.6e-05	5.24e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—KRAS—stomach cancer	2.56e-05	5.16e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PIK3CA—stomach cancer	2.55e-05	5.14e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CDKN1B—stomach cancer	2.54e-05	5.11e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KRAS—stomach cancer	2.5e-05	5.04e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCND1—stomach cancer	2.42e-05	4.88e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—JUN—stomach cancer	2.41e-05	4.87e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HRAS—stomach cancer	2.36e-05	4.75e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PIK3CA—stomach cancer	2.35e-05	4.74e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MMP9—stomach cancer	2.35e-05	4.74e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CDKN1A—stomach cancer	2.34e-05	4.72e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PIK3CA—stomach cancer	2.3e-05	4.63e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MAPK8—stomach cancer	2.28e-05	4.61e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL6—stomach cancer	2.26e-05	4.55e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TP53—stomach cancer	2.22e-05	4.48e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HRAS—stomach cancer	2.18e-05	4.39e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HRAS—stomach cancer	2.12e-05	4.28e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—VEGFA—stomach cancer	2.11e-05	4.25e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—STAT3—stomach cancer	2.09e-05	4.21e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IL6—stomach cancer	2.08e-05	4.2e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL6—stomach cancer	2.03e-05	4.1e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MAPK3—stomach cancer	2e-05	4.02e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PIK3CA—stomach cancer	1.97e-05	3.97e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MYC—stomach cancer	1.94e-05	3.91e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MAPK1—stomach cancer	1.9e-05	3.83e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EGFR—stomach cancer	1.9e-05	3.83e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KRAS—stomach cancer	1.79e-05	3.62e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PIK3CA—stomach cancer	1.65e-05	3.32e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TP53—stomach cancer	1.59e-05	3.21e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HRAS—stomach cancer	1.52e-05	3.07e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL6—stomach cancer	1.46e-05	2.94e-05	CbGpPWpGaD
